| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Mar 09, 2026 |
uniQure N.V.
QURE
|
BUY |
$31.00
Est. +72%
|
$17.99 | $50.47 |
Target Met
|
$41.81
+132.4%
|
| Jan 02, 2026 |
Outlook Therapeutics Inc
OTLK
|
BUY |
$1.00
Est. +52%
|
$0.66 | $1.88 |
Target Met
|
$1.45
+119.7%
|
| Dec 23, 2025 |
Annexon Inc
ANNX
|
BUY |
$16.00
Est. +208%
|
$5.19 | $7.18 |
Pending
|
$5.46
+5.2%
|
| Nov 03, 2025 |
uniQure N.V.
QURE
|
BUY |
$53.00
Est. +55%
|
$34.18 | $50.47 |
Pending
|
$41.81
+22.3%
|
| Sep 18, 2024 |
CervoMed Inc
CRVO
|
BUY |
$55.00
Est. +1048%
|
$4.79 | $19.50 |
Miss
|
$3.55
-25.9%
|
| May 08, 2022 |
Ocugen Inc
OCGN
|
BUY |
$3.50
Est. +62%
|
$2.16 | - | - |
$1.51
-30.1%
|